← Back to headlines
Study Reveals Most New Drugs in Europe Offer Little Therapeutic Value
A new study indicates that out of 330 new drugs approved in Europe between 2015 and 2024, only one has been shown to provide significant therapeutic added value. A researcher states that citizens have a right to be aware of this finding.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
